Method for generating a three-dimensional nucleic acid containing matrix

US10138509B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10138509-B2
Application numberUS-201414774282-A
CountryUS
Kind codeB2
Filing dateFeb 26, 2014
Priority dateMar 12, 2013
Publication dateNov 27, 2018
Grant dateNov 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods of making a three-dimensional matrix of nucleic acids within a cell is provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of identifying nucleic acids within a cell, comprising: contacting a plurality of nucleic acids having a relative three-dimensional spatial relationship within the cell with a matrix-forming material in a manner to substantially retain the relative three-dimensional spatial relationship; using the matrix-forming material to form a three-dimensional polymerized matrix including the nucleic acids of the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix; and detecting signals from the nucleic acids or derivatives thereof, thereby identifying the nucleic acids. 2. The method of claim 1 further including the step of amplifying the nucleic acids to produce amplicons within the three-dimensional polymerized matrix. 3. The method of claim 2 further including the step of covalently bonding the amplicons to the three-dimensional polymerized matrix. 4. The method of claim 1 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample. 5. The method of claim 1 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell. 6. The method of claim 1 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample. 7. A method of identifying one or more nucleic acids within a cell comprising: contacting a plurality of nucleic acids having a relative three-dimensional spatial relationship within the cell with a matrix-forming material to form a three-dimensional polymerized matrix comprising the plurality of nucleic acids coupled to the three-dimensional polymerized matrix, wherein the relative three-dimensional spatial relationship is substantially retained in the three-dimensional polymerized matrix; amplifying the plurality of nucleic acids to produce amplicons within the three-dimensional polymerized matrix; coupling the amplicons to the three-dimensional polymerized matrix; and detecting the amplicons to identify a sequence of the one or more nucleic acids. 8. A method of identifying a relative three-dimensional spatial relationship of one or more nucleic acids within a cell comprising: contacting a plurality of nucleic acids having the relative three-dimensional spatial relationship within the cell with a matrix-forming material in a manner to substantially retain the relative three-dimensional spatial relationship; using the matrix-forming material to form a three-dimensional polymerized matrix including the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix; amplifying the plurality of nucleic acids to produce amplicons within the matrix, covalently bonding the amplicons to the three-dimensional polymerized matrix; labeling the amplicons with a detectable label; and imaging the amplicons to identify the relative three-dimensional spatial relationship of the one or more nucleic acids within the cell. 9. The method of claim 7 wherein the plurality of nucleic acids are circular. 10. The method of claim 7 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample. 11. The method of claim 7 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell. 12. The method of claim 7 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample. 13. The method of claim 8 wherein the plurality of nucleic acids are contained within a biological sample and the matrix-forming material is introduced into the biological sample. 14. The method of claim 8 wherein the plurality of nucleic acids are contained within a cell and the matrix-forming material is introduced into the cell. 15. The method of claim 8 wherein the plurality of nucleic acids are contained within a tissue sample and the matrix-forming material is introduced into the tissue sample. 16. The method of claim 1 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix. 17. The method of claim 1 wherein the matrix-forming material comprises polyacrylamide, cellulose, alginate, polyamide, cross-linked agarose, cross-linked dextran or cross-linked polyethylene glycol. 18. The method of claim 7 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix. 19. The method of claim 8 wherein the relative three-dimensional spatial relationship of each nucleic acid of the plurality of nucleic acids is immobilized within the three-dimensional polymerized matrix. 20. The method of claim 7 wherein contacting the plurality of nucleic acids having the relative three-dimensional spatial relationship within the cell with the matrix-forming material comprises subjecting the matrix-forming material to a polymerization inducing catalyst, ultraviolet (UV) light, or functional cross-linkers. 21. The method of claim 7 wherein coupling the amplicons to the three-dimensional polymerized matrix comprises covalently bonding the amplicons to the three-dimensional polymerized matrix. 22. The method of claim 7 wherein the three-dimensional polymerized matrix comprises the plurality of nucleic acids covalently bound to the three-dimensional polymerized matrix. 23. The method of claim 7 wherein the amplicons are labeled with a detectable label. 24. The method of claim 1 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking. 25. The method of claim 1 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization. 26. The method of claim 7 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking. 27. The method of claim 7 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization. 28. The method of claim 8 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to cross-linking. 29. The method of claim 8 , wherein the three-dimensional polymerized matrix is formed by subjecting the matrix-forming material to polymerization. 30. The method of claim 2 , wherein amplifying the nucleic acids comprises performing polymerase chain reaction (PCR) on the nucleic acids. 31. The method of claim 2 , wherein amplifying the nucleic acids comprises performing isothermal enzymatic amplification on the nucleic acids. 32. The method of claim 2 , wherein the amplicons are labeled with a detectable label. 33. The method of claim 7 , wherein amplifying the plurality of nucleic acids comprises performing PCR on the plurality of nucleic acids. 34. The method of claim 7 , wherein amplifying the plurality of nucleic acids comprises p

Assignees

Inventors

Classifications

  • Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

  • Nucleic acid amplification reactions · CPC title

  • Methods for sequencing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10138509B2 cover?
Methods of making a three-dimensional matrix of nucleic acids within a cell is provided.
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).